CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced that it will present at the Cantor Global Healthcare Conference on Thursday, October 3, 2019, at 10:05 a.m. ET in New York, NY. A live webcast of the presentation will be available on the Company’s website at An audio [...]